23
General Information
DRACP ID DRACP00166
Peptide Name 23
Sequence YGGFMX
Sequence Length 6
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HEp-2 | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | 3.9% inhibition at 10-5 M, 45.0% inhibition at 10-3 M | MTT assay | 72 h | 1 |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | 9.3% inhibition at 10-3 M | MTT assay | 72 h | 1 |
HBL | Melanoma | Carcinoma | 4.1% inhibition at 10-6 M, 70.7% inhibition at 10-5 M, 34.2% inhibition at 10-3 M | MTT assay | 72 h | 1 |
HT-29 | Colon adenocarcinoma | Carcinoma | 9.2% inhibition at 10-3 M | MTT assay | 72 h | 1 |
CaCo-2 | Colon adenocarcinoma | Carcinoma | 11.8% inhibition at 10-5 M, 47.0% inhibition at 10-3 M | MTT assay | 72 h | 1 |
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | 2.2% inhibition at 10-6 M, 7.1% inhibition at 10-5 M, 6.9% inhibition at 10-4 M, 25.9% inhibition at 10-3 M | MTT assay | 72 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism lead to apoptosis
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification X=Cαα -dialkylated glycine (Aaa1 )
Chiral L
Physicochemical Information
Formula C27H33N5O6S
Absent amino acids ACDEHIKLNPQRSTVW
Common amino acids G
Mass 75501
Pl 6.09
Basic residues 0
Acidic residues 0
Hydrophobic residues 1
Net charge 0
Boman Index 707
Hydrophobicity 43.33
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 1490
Absorbance 280nm 298
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16722632
Title Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity
Doi 10.1021/jm051026
Year +2006
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available